The latest on PANCREASaver® — from lab to bedside, we keep moving.
Storm Media announces the AI Healthcare Innovation Awards (AIHIA) — AI moving from prevention and treatment to island-wide integration, 8 innovative applications marking a new milestone in smart healthcare; PANCREASaver® is recognized for breaking the early-detection bottleneck of the "king of cancers."
"The biggest challenge in medical AI is not technology — it is trust." Director Kai-Chun Yang and Dr. Wei-Chih Liao share in a Storm Media interview how PANCREASaver® enters clinical practice without changing physicians' workflows: "AI should adapt to medicine, not the other way around."
At the Asian Pacific Digestive Week in Japan, the team presented real-world data from 300+ interpreted cases: sensitivity matches clinical trials, with stable AI performance in busy daily radiology.
PanCAD.ai announced partnerships with multiple health centers to bring pancreatic AI screening into routine abdominal checkups — from medical centers to regional hospitals to health centers.
Since the FDA Breakthrough Device designation in 2024, PANCREASaver® continues talks with international institutions; ten patents in Taiwan & the US are taking shape.
Another national recognition — 9 awards in total: RSNA Margulis (first for Taiwan), SNQ, Taipei BioTech, National Innovation Award and more.
The study appeared in the top journal Radiology, providing independent, reproducible academic backing for PANCREASaver®'s algorithm.
Starting from National Taiwan University Hospital, PANCREASaver® now serves multiple institutions — every patient, a protected family.